CurifyLabs Launches CuraBlend Vet: 3D-Printed Veterinary Medicine as a Dosable, Chewable Gel Tablet

In veterinary practices, treatment often fails not because of active ingredients, but because of dosage form and dosing. For many indications, there are no ready-made, species-specific strengths. Pharmacies then resort to conversions from human medicines, crush tablets, or manually compound formulations. These workflows are time-consuming and prone to variability—for example due to uneven drug distribution or deviations during weighing.

CurifyLabs aims to address this problem with CuraBlend Vet, a new excipient system for its CurifyLabs Compounding System Solution (CSS). The approach relies on a standardized 3D-printing process chain that runs automatically and is digitally documented. Instead of individual manual steps such as grinding, sieving, mixing, and portioning, the platform is intended to produce reproducible doses in a short time. CuraBlend Vet serves as a defined matrix that can be processed in the system and is meant to support process stability and batch-to-batch consistency.

The second bottleneck is adherence. Many animals refuse medication if the smell or taste is off; missed doses then become the norm rather than the exception. CurifyLabs therefore uses a flavored, chewable gel tablet that feels and tastes more like a treat. In a company-described study involving 31 dogs and 38 cats, a large majority voluntarily consumed the flavored tablets, while unflavored versions were often rejected.

“Pet owners want medication time to be simple, not stressful,” said Charlotta Topelius, CEO and Founder of CurifyLabs. “CuraBlend Vet gives pharmacists a reliable way to make pet-friendly medicines that animals actually want to eat.”

CurifyLabs also notes that its 3D-printing platform is already used in clinics and pharmacies in the United States and Europe for personalized human medicines, and is now being extended to veterinary care.

“We know how important pets are to families,” Topelius added. “And we’re proud that CuraBlend Vet now brings the benefits of trusted 3D-printed medicine to veterinary care.”

In practice, the value will be measured by whether acceptance, dosing accuracy, and documentation actually improve in day-to-day use—without slowing compounding work through new validation and release steps.